Providing AI dermatology solutions in partnership with the NHS
Reducing costs and adding valuable benefits
Our unique AI technology provides dermatology capacity by identifying 11 different lesion types. These range from malignant and pre-malignant lesions that can be treated if assessed early enough, through to benign lesions where patients can be discharged or referred for further monitoring.
DERM AI can sit in existing medical photography hubs for teledermatology, and be able to discharge 30-40% of cases initially. Additional capacity gains can be made should the dermatologists be happy to list the malignant lesions directly for biopsy, saving another dermatology appointment per listed patient.
Lasting Benefits
- Takes seconds to assess patients
- Up to 60% reduction in referrals
- Patients can be assessed by GPs, Nurses and HCSs to the level of a dermatologist
- Secure AI and information storage
- Identifies 11 lesion types from cancer to benign
- Class 1 Medical device
Clients
Latest News
Deploying Safe and Effective AI in Skin Cancer Pathways
26 January 2021 In December, the British Association of Dermatologist (BAD) President’s Bulletin included an article...
Skin Analytics response to NHS AI Code of Conduct
In July 2019 the Department of Health and Social Care and NHS England published a new code of conduct for the use of...
Skin Analytics Awarded ISO 13485 Certification
Skin Analytics is delighted to announce that we are now ISO 13485:2016 certified. ISO 13485:2016 is an internationally...